Choice Help: Optimizing Outcomes by Supporting Encounters for Kids with Congenital Melanocytic Nevi

Carrie Coughlin M.D.

We need tools to support shared decision-making in pediatric dermatology as well as studies evaluating this process. Choice Help: Optimizing Outcomes by Supporting Encounters for kids with Congenital Melanocytic Nevi (CHOOSE CMN) aims to (1) elicit patient/family values informing medical decision-making for patients with congenital nevi, and (2) test the feasibility of a patient decision aid concerning neural melanosis screening and surgical interventions.

— Carrie C. Coughlin, M.D.

Related Articles

Crystal Aguh M.D.

Exploring Gene Expression Patterns and Biomarkers of Disease Severity in Central Centrifugal Cicatricial Alopecia

Central centrifugal cicatricial alopecia (CCCA), which has been associated with uterine fibroids, is unlike other scarring alopecias because fibrosis rather…

Read More

Characterizing the Microbiome in Postmenopausal Women with Vulvar Lichen Sclerosus

Vulvar lichen sclerosus is a chronic inflammatory condition that leads to scarring, obliteration of normal vulvar architecture, dyspareunia, and significant…

Read More

Cell Signaling Changes Induced by Surgical Debulking May Improve Response to Smoothened Inhibitor Therapy

Smoothened (SMO) inhibitors, such as vismodegib, are effective treatments for locally advanced basal cell carcinomas (BCCs). However, recurrences are frequent…

Read More